Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Dashemani Kandughna gel: 120 patients with of Darunak ( Dandruff)will be treated with Dashemani Kandughna gel approximately 10 gm for Topical application daily at night time(HS) on sca
Sponsors
Dr Nilima Sanjay Dharkar
Eligibility
Inclusion criteria
Inclusion criteria: 1) Volunteers willing to participate and giving informed consent will be included in study 2) Patients of Either sex, age group18-50, suffering from Darunak (Dandruff )
Exclusion criteria
Exclusion criteria: 1) Volunteers not willing to participate and giving informed consent 2) Age less than 18yrs or more than 50 yrs 3) Seborrheric dermatitis, Psoriasis of scalp,Eczema of scalp 4) Immune compromised conditions and systemic infections
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality standards will be generated for newly innovated Dashemani Kandughna Gel. Dashemani Kandughna Gel may show antimicrobial activity as against specific bacterial and fungal strains Dashemani Kandughna Gel might show antidandruff action inpubertal to middle age volunteers of age 18 to 50 years. Timepoint: Quality standards will be generated for newly innovated Dashemani Kandughna Gel. Dashemani Kandughna Gel may show antimicrobial activity as against specific bacterial and fungal strains Dashemani Kandughna Gel might show antidandruff action inpubertal to middle age volunteers of age 18 to 50 yearswith topical application f0r 21 days at night time daily.Weekly assessment will be done at 0, 7, 14, 21 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any untoward effec ts of Kadughna Dashemani gel during the studyTimepoint: During the study period of 21 days | — |
Countries
India
Contacts
Public ContactDr Madhuri Pawar
College of Ayurved Bharati Vidyapeeth Pune
Outcome results
None listed